Company Milestones
2016

In February,   Hepalink Hongkong invested and established “ORI Healthcare Fund, L.P.”

In May,           Hepalink Recognized as “International brand Credibility”

In June,          Hepalink Honored with “Globalization–Top 10 out of Shenzhen 100

                       Transformation Enterprises”

In November, Hepalink Hongkong invested “Kymab Group Limited”

In December, Hepalink “R & D Laboratory” obtained “Laboratory Accreditation Certificate”

                       from CNAS